Thalidomide induces clinical remission and mucosal healing in adults with active Crohn’s disease: a prospective open-label study

BACKGROUND: Thalidomide is effective in inducing and maintaining clinical remission in children and adolescents with refractory Crohn’s disease (CD). However, little is known about the efficacy and safety of thalidomide for adult patients with CD. METHODS: We conducted a prospective open-label cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yao, Mao, Ren, Chen, Fang, Xu, Ping-Ping, Chen, Bai-Li, Wu, Yun, Qiu, Yun, Zhang, Sheng-Hong, Feng, Rui, Zeng, Zhi-Rong, Ben-Horin, Shomron, Chen, Min-Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415099/
https://www.ncbi.nlm.nih.gov/pubmed/28507598
http://dx.doi.org/10.1177/1756283X17698910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415099/
https://www.ncbi.nlm.nih.gov/pubmed/28507598
http://dx.doi.org/10.1177/1756283X17698910

Ejemplares similares